MAIA BIOTECHNOLOGY INC
MAIA·552641102·US·Common Stock·Healthcare - Biotechnology-Activist
MAIA (MAIA BIOTECHNOLOGY INC) is held by 19 institutional investors as of Q1 2026. Largest holders: Alyeska Investment Group, L.P. ($3.5M), VANGUARD CAPITAL MANAGEMENT LLC ($2.9M), GEODE CAPITAL MANAGEMENT, LLC ($504,910). Net institutional sentiment: Bullish.
19
Holders
Avg rating(4 Elite)
$7.8M
Total Value
72% (22)
Fund Consensus
13 buying - 5 selling
Who's Trading
InsiderSSSmith StanBuy $100KJun 1, 2026
InsiderVVVitoc VladBuy $101KJun 1, 2026
InsiderGSGryaznov SergeiBuy $3KJun 1, 2026
ActivistSOSolas Capital Management, LLC7.1%May 15, 2026
InsiderSSSmith StanBuy $70KDec 22, 2025
InsiderLYLouie Ngar YeeBuy $100KDec 22, 2025
InsiderCMCHAOUKI STEVEN MBuy $50KDec 22, 2025
InsiderSSSmith StanBuy $5KDec 5, 2025
InsiderSSSmith StanBuy $5KDec 5, 2025
ActivistVVVlad Vitoc9.7%Dec 4, 2025
13F: Insider & Congress:
Showing 1-20 of 22
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer